PAPOLA Antibody [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-55267IR
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Bovine (100%), Mouse (100%). Backed by our 100% Guarantee.
Applications
Immunoprecipitation, Western Blot (Negative)
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen recognized by this antibody maps to a region between residue 525 and 575 of human poly(A) polymerase alpha using the numbering given in entry NP_116021.2 (GeneID 10914).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for PAPOLA Antibody [DyLight 755]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot (Negative)
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PAPOLA
Long Name
Poly(A) polymerase alpha
Alternate Names
EC 2.7.7.19, PAP, PAP-alpha
Gene Symbol
PAPOLA
Additional PAPOLA Products
Product Documents for PAPOLA Antibody [DyLight 755]
Product Specific Notices for PAPOLA Antibody [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...